Carr

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 DANIELLE CARR, Case No. 20-cv-07625-EMC

Plaintiff,

ORDER GRANTING DEFENDANTS’

v. MOTION TO DISMISS

ZOSANO PHARMA CORPORATION, Docket No. 71 et al., 11 Defendants. 12 13 I. INTRODUCTION This case is a securities-fraud class action brought by co-lead Plaintiffs Tuk Doss and Hosam Alqurashi (“Plaintiffs”) against Defendants Zosano Pharma Corporation (“Zosano”) and three of the company’s current or former CEOs: Steven Lo, John Walker, and Konstantinos Alataris. See Docket No. 68 (“CAC”) at 1, ¶¶ 18-23. Plaintiffs allege that, from February 13, 2017, through October 20, 2020 (the “Class Period”), Defendants made a series of misleading statements about the likelihood of regulatory approval by the U.S. Food and Drug Administration (“FDA”) of the company’s principal product, Qtrypta, and that these statements violate Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (“Exchange Act”) as well as …